In cancer cells, CD36 could also regulate cell proliferation, glycolysis, and Epithelial-Mesenchymal Transition (EMT) through the MAPK, AKT, and STAT3 signaling pathways to determine the physiological and pathological processes of cells (Figure 1) (40–42). The gene discussed is CD36; the disease is cancer.